|
Volume
24 Number 20
31 October 2022
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
24, Year 2022 >
Number 20, 31 October
|
|
|
|
|
|
Zhang J, Siller-Farfán JA.
Current
and future perspectives of chimeric antigen receptors against
glioblastoma.
Immunother Adv. 2022 Jun 1,
2022;2(1):ltac014→.
doi: 10.1093/immadv/ltac014→.
PMID: 36284838→.
Review. →
|
|
|
|
Khalil M, Shah Z, Saeed Baqai MW, Shamim MS.
Intraoperative
Seizures During Awake Craniotomy for Brain Tumours.
J
Pak Med Assoc. 2022 Sep;72(9):1878-1879→.
doi: 10.47391/JPMA.22-95? PMID: 36281000→.
Review. →
|
|
|
|
Li Y, Qin Q, Zhang Y, Cao Y.
Noninvasive
Determination of the IDH Status of Gliomas Using MRI and MRI-Based
Radiomics: Impact on Diagnosis and Prognosis.
Curr
Oncol. 2022 Sep 23, 2022;29(10):6893-6907→.
doi: 10.3390/curroncol29100542→.
PMID: 36290819→.
Review. →
|
|
|
|
Lim-Fat MJ, Macdonald M, Lapointe S, Climans SA, Cacciotti C,
Chahal M, Perreault S, Tsang DS, Gao A, Yip S, Keith J, Bennett J,
Ramaswamy V, Detsky J, Tabori U, Das S, Hawkins C.
Molecular
testing for adolescent and young adult central nervous system
tumors: A Canadian guideline.
Front Oncol. 2022
Sep 23, 2022;12:960509→.
doi: 10.3389/fonc.2022.960509→.
PMID: 36249063→.
Guidelines. →
|
|
|
|
Rossi J, Cavallieri F, Biagini G, Rizzi R, Russo M, Cozzi S,
Giaccherini L, Pisanello A, Valzania F.
Epileptogenesis
and Tumorigenesis in Glioblastoma: Which Relationship?
Medicina
(Kaunas). 2022 Sep 26, 2022;58(10):1349→.
doi: 10.3390/medicina58101349→.
PMID: 36295510→.
Review. →
|
|
|
|
Song S, Wu H, Wang F, Jiao J, Xu L, Wang H, Tong X, Yan H.
Global
research trends and hotspots on glioma stem cells.
Front
Oncol. 2022 Sep 29, 2022;12:926025→.
doi: 10.3389/fonc.2022.926025→.
PMID: 36248966→.
Bibliometric analysis. →
→
→
|
|
|
|
Zhou Y, Fang C, Xu H, Yuan L, Liu Y, Wang X, Zhang A, Shao A, Zhou
D.
Ferroptosis in glioma treatment:
Current situation, prospects and drug applications.
Front
Oncol. 2022 Sep 29, 2022;12:989896→.
doi: 10.3389/fonc.2022.989896→.
PMID: 36249003→.
Review. →
|
|
|
|
Buccarelli M, Castellani G, Ricci-Vitiani L.
Glioblastoma-Specific
Strategies of Vascularization: Implications in Anti-Angiogenic
Therapy Resistance.
J Pers Med. 2022 Oct 1,
2022;12(10):1625→.
doi: 10.3390/jpm12101625→.
PMID: 36294763→.
Review. →
|
|
|
|
Daneshimehr F, Barabadi Z, Abdolahi S, Soleimani M, Verdi J,
Ebrahimi-Barough S, Ai J.
Angiogenesis
and Its Targeting in Glioblastoma with Focus on Clinical
Approaches.
Cell J. 2022 Oct 1,
2022;24(10):555-568→.
doi: 10.22074/cellj.2022.8154→.
PMID: 36259473→.
Review. →
|
|
|
|
Guha A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole
S.
Classifying primary central
nervous system lymphoma from glioblastoma using deep learning and
radiomics based machine learning approach - a systematic review
and meta-analysis.
Front Oncol. 2022 Oct 3,
2022;12:884173→.
doi: 10.3389/fonc.2022.884173→.
PMID: 36263203→.
Review, Meta-analysis. →
|
|
|
|
Choi SI, Yin J.
Prospective
approaches to enhancing CAR T cell therapy for glioblastoma.
Front
Immunol. 2022 Oct 6, 2022;13:1008751→.
doi: 10.3389/fimmu.2022.1008751→.
PMID: 36275671→.
Review. →
|
|
|
|
Sánchez-Villalobos JM, Aledo-Serrano Á,
Villegas-Martínez I, Shaikh MF, Alcaraz M.
Epilepsy
treatment in neuro-oncology: A rationale for drug choice in common
clinical scenarios.
Front Pharmacol. 2022 Oct 6,
2022;13:991244→.
doi: 10.3389/fphar.2022.991244→.
PMID: 36278161→.
Review. →
|
|
|
|
Bartusik-Aebisher D, Żołyniak A, Barnaś E,
Machorowska-Pieniążek A, Oleś P, Kawczyk-Krupka A,
Aebisher D.
The Use of Photodynamic
Therapy in the Treatment of Brain Tumors-A Review of the
Literature.
Molecules. 2022 Oct 13,
2022;27(20):6847→.
doi: 10.3390/molecules27206847→.
PMID: 36296440→.
Review. →
|
|
|
|
van Bree NFHN, Wilhelm M.
The Tumor
Microenvironment of Medulloblastoma: An Intricate Multicellular
Network with Therapeutic Potential.
Cancers
(Basel). 2022 Oct 13, 2022;14(20):5009→.
doi: 10.3390/cancers14205009→.
PMID: 36291792→.
Review. →
|
|
|
|
Gaca-Tabaszewska M, Bogusiewicz J, Bojko B.
Metabolomic
and Lipidomic Profiling of Gliomas-A New Direction in Personalized
Therapies.
Cancers (Basel). 2022 Oct 14,
2022;14(20):5041→.
doi: 10.3390/cancers14205041→.
PMID: 36291824→.
Review. →
|
|
|
|
Gueble SE, Vasquez JC, Bindra RS.
The
Role of PARP Inhibitors in Patients with Primary Malignant Central
Nervous System Tumors.
Curr Treat Options Oncol.
2022 Oct 15, 2022;23(11):1566-1589→.
doi: 10.1007/s11864-022-01024-5→.
PMID: 36242713→.
Review˰ →
|
|
|
|
|
|
Knisely JPS, Fine HA.
Reirradiation
for Recurrent Glioblastoma: What We Know and What We Do Not.
J
Clin Oncol. 2022 Oct 19, 2022:JCO2201785→.
doi: 10.1200/JCO.22.01785→.
PMID: 36260825→.
Case report, Review. →
|
|
|
|
Mackenzie P, Vajdic C, Delaney G, Comans T, Morris L, Agar M,
Gabriel G, Barton M.
Radiotherapy
utilisation rates for patients with cancer as a function of age: A
systematic review.
J Geriatr Oncol. 2022 Oct 19,
2022:S1879-4068(22)00236-3→.
doi: 10.1016/j.jgo.2022.10.002→.
PMID: 36272958→.
Review˰ →
|
|
|
|
Niemi JVL, Sokolov AV, Schiöth HB.
Neoantigen
Vaccines; Clinical Trials, Classes, Indications, Adjuvants and
Combinatorial Treatments.
Cancers (Basel). 2022
Oct 21, 2022;14(20):5163→.
doi: 10.3390/cancers14205163→.
PMID: 36291947→.
Review. →
|
|
|
|
Sachdeva P, Ghosh S, Ghosh S, Han S, Banerjee J, Bhaskar R, Sinha
JK.
Childhood Obesity: A Potential
Key Factor in the Development of Glioblastoma Multiforme.
Life
(Basel). 2022 Oct 21, 2022;12(10):1673→.
doi: 10.3390/life12101673→.
PMID: 36295107→.
Review. →
|
|
|
|
Yuile A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei
H, Buckland ME, Lee A, Wheeler HR.
Implications
of Concurrent IDH1
and IDH2
Mutations on Survival in Glioma-A
Case Report and Systematic Review.
Curr Issues Mol
Biol. 2022 Oct 21, 2022;44(10):5117-5125→.
doi: 10.3390/cimb44100348→.
PMID: 36286062→.
Case report, Review. →
|
|
|
|
Fioni F, Song JC, Ma ZL, Ghalwash AA.
Differentiation
of high grade glioma and solitary brain metastases by measuring
relative cerebral blood volume and fractional anisotropy: A
systematic review and Meta-Analysis of MRI diagnostic test
accuracy studies.
Br J Radiol. 2022 Oct 24,
2022:20220052→.
doi: 10.1259/bjr.20220052→.
PMID: 36278795→.
Review, Meta-analysis. →
|
|
|
|
Bunse L, Bunse T, Krämer C, Chih YC, Platten M.
Clinical
and Translational Advances in Glioma
Immunotherapy.
Neurotherapeutics. 2022 Oct 27→.
doi: 10.1007/s13311-022-01313-9→.
PMID: 36303101→.
Review. →
|
|
|
|
Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera
V, Basso G, Moresco RM, Giussani C, Bentivegna A.
The
peritumoral brain zone in glioblastoma: where we are and where we
are going.
J Neurosci Res. 2022 Oct 27→.
doi: 10.1002/jnr.25134→.
PMID: 36300592→.
Review. →
|
|
|
|
Hosseinalizadeh H, Habibi Roudkenar M, Mohammadi Roushandeh A,
Kuwahara Y, Tomita K, Sato T.
Natural
killer cell immunotherapy in glioblastoma.
Discov
Oncol. 2022 Oct 28, 2022;13(1):113→.
doi: 10.1007/s12672-022-00567-1→.
PMID: 36305981→.
Review. →
|
|
|
|
Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, Pritam P,
Ramgopal K, Liu W, Hou K.
Antioxidants
in brain tumors: current therapeutic significance and future
prospects.
Mol Cancer. 2022 Oct 28,
2022;21(1):204→.
doi: 10.1186/s12943-022-01668-9→.
PMID: 36307808→.
Review. →
|
|
|
|
|
|
|
|
|
